Influence
July 16, 2020

Regenstrief research scientist shares ICU experience during Side Effects COVID-19 panel

Regenstrief research scientist Sikandar Khan, D.O., shared his perspective from working in the intensive care unit (ICU) in the midst of the COVID-19 outbreak during a panel hosted by Side Effects Public Media and Indiana Public Broadcasting.

Dr. Khan has been treating patients in the ICU at Indiana University Health Methodist Hospital throughout the COVID-19 pandemic. He spoke about how data has helped guide decisions in the ICU, allowing clinicians to anticipate surges in cases and plan for equipment and personnel needs.

He also talked about the potentially long recovery COVID-19 survivors face. Patients who need intensive care, especially those who are put on ventilators, are at risk for post intensive care syndrome. This can affect the patient’s body as well as the mind. Dr. Khan said he and his colleagues are closely watching to see what recovery will look like for COVID-19 patients.

Dr. Khan also lauded his colleagues for adapting to the stressful situation and their tireless work to take care of patients. He urged everyone to continue taking precautions, including social distancing and wearing masks.

Watch the entire panel here

Related News

Regenstrief Institute and Suki partner to evaluate ambient AI in healthcare

Organizations share a commitment to understanding how ambient AI technologies impact clinicians, patients and healthcare delivery  Regenstrief Institute and Suki, a

Dr. Peter J. Embi

Regenstrief’s legacy with the National Library of Medicine continues

Peter J. Embí, M.D., M.S., former president and CEO of the Regenstrief Institute, has been appointed director of the

image showing two people connecting through a kidney

Regenstrief Institute awarded KidneyX prize to advance living kidney donation

LIVINGkidney digital tool recognized in national HHS competition focused on reducing barriers for living kidney donors and transplant patients  Regenstrief

LOINC® version 2.83 enhances global health data exchange through new terminology and implementation improvements

Release expands terminology for drug and toxicology testing, microbiology, public health reporting and allergy information Regenstrief Institute has released